From startups to legacy brands, you're making your mark. We're here to help.
Key Links
Prepare for future growth with customized loan services, succession planning and capital for business equipment.
Key Links
Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.
Key Links
Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.
Your partner for commerce, receivables, cross-currency, working capital, blockchain, liquidity and more.
Key Links
A uniquely elevated private banking experience shaped around you.
Whether you want to invest on your own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.
For Companies and Institutions
From startups to legacy brands, you're making your mark. We're here to help.
Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.
Your partner for commerce, receivables, cross-currency, working capital, blockchain, liquidity and more.
Prepare for future growth with customized loan services, succession planning and capital for business equipment.
Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.
For Individuals
A uniquely elevated private banking experience shaped around you.
Whether you want to invest on you own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.
Explore a variety of insights.
Key Links
Insights by Topic
Explore a variety of insights organized by different topics.
Key Links
Insights by Type
Explore a variety of insights organized by different types of content and media.
Key Links
We aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.
Key Links
Venture investment in biopharma and medtech companies continues to trend upward through the third quarter of 2024.
The total amount of capital invested in biopharma therapeutics and discovery platforms remained strong in the third quarter of 2024, maintaining a pace that could result in higher total investment for the year compared to 2023. Medtech followed a similar trend and continues to move in a positive direction with 2024 full-year investments also on track to outpace the total amount of capital invested last year.
Medtech M&A remained active through Q3 2024 compared to prior periods; the total amount of medtech M&A deals through Q3 has already surpassed 2023’s full-year total.
J.P. Morgan’s biopharma therapeutics and medtech licensing reports explore the movement in each sector, offering insight into industry and investment trends that defined the third quarter of 2024 and are shaping the remainder of the year. The reports, powered by DealForma, highlight:
Download the full reports to better understand these dealmaking trends and reach out to J.P. Morgan to connect with a Startup Banking expert.
Kathryn McDonough
Head of Life Sciences, Innovation Economy, Commercial Banking, J.P. Morgan
Skip Kelly
Head of Healthcare VC Coverage, Commercial Banking, J.P. Morgan
Outlook
October 2024 CPI report: Inflation met expectations, supporting the Fed’s easing path
Nov 14, 2024
The October 2024 CPI report met economists' expectations, supporting the Fed's easing path despite a slight year-over-year increase from 2.4% to 2.6%.
Outlook
Eye on the Market: Kamilton: the 2024 election and who tells your story
Nov 07, 2024
In this edition of Eye on the Market, Michael Cembalest, Chairman of Market and Investment Strategy for J.P. Morgan Asset and Wealth Management, looks at the Trump victory, market implications of a supply side boost from deregulation and more.
Outlook
October 2024 jobs report: Only 12,000 jobs added, tempered by disruptions
Nov 04, 2024
U.S. job growth grew by the slowest pace since 2020. Our strategists believe this softer report will keep the Fed on its programmatic rate-cutting cycle.
Outlook
Eye on the Market: The Thucydides cap on the China equity rebound trade
Oct 17, 2024
In this edition of Eye on the Market, Michael Cembalest, Chairman of Market and Investment Strategy for J.P. Morgan Asset and Wealth Management, explains what China’s equity rebounds might mean for participants’ returns.
Outlook
September 2024 CPI report: Inflation fell to 2.4%, moving closer to the Fed’s 2% target
Oct 11, 2024
The uptick in September’s core CPI reminds us that inflation pressure hasn’t fully dissipated, which should keep the Fed on a gradual pace of rate cuts going forward.
Outlook
September 2024 jobs report: 254,000 jobs added, defying expectations
Oct 07, 2024
U.S. job growth unexpectedly accelerated sharply beyond economists’ expectations, solidifying our strategists’ view that the Fed will lower interest rates by 25 basis points at its next meeting.
Outlook
Eye on the Market: Mind the gap
Sep 30, 2024
In this edition of Eye on the Market, Michael Cembalest, Chairman of Market and Investment Strategy for J.P. Morgan Asset and Wealth Management, looks at presidential candidate policy differences and implications for investors.
Outlook
Embracing opportunity in uncertain and volatile times
Sep 26, 2024
J.P. Morgan Wealth Management hosted a webcast breaking down current trends and their impact on markets. Here’s how investors can make smart decisions as 2024 comes to an end.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.